Refinement and Clinical Evaluation of the H-Man for Arm Rehabilitation After Stroke
![]() |
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT02188628 |
Recruitment Status :
Completed
First Posted : July 11, 2014
Last Update Posted : September 12, 2019
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
Locally, stroke remains the 4th cause of death, causing 8.4% of deaths annually in Singapore, and a leading cause of neurological disability worldwide. Nearly 40% of the stroke survivors will require specialized rehabilitation. In recent years, robot-aided therapy has been proposed as a means of complementing traditional therapy to alleviate the burden on therapists and on the healthcare system. For shoulder/elbow rehabilitation, dozens of robots have been proposed in the literature but only half a dozen have been commercialized and typically none are seen in local clinics, due to exceedingly high costs. A novel, compact, inexpensive robotic interface, named 'H-Man', was recently designed and developed at NTU for experiments in motor control neuroscience. The H-man can generate computer-controlled force fields to assist or resist a subject's motion and is potentially an optimal trade-off between clinical efficacy and robotic complexity. A first prototype of the H-Man is available at NTU.The primary aim of this proposed project is to assess to what extent the investigators H-Man is suitable for rehabilitation purposes using a feasibility pilot clinical trial design involving stroke survivors. The investigators believe that H-Man can be used for neuro-rehabilitation of stroke patients with hemiparetic weakness, motor incoordination and motor ataxia of the upper limbs.In close cooperation between clinicians at the TTSH and NTU engineers, a portable version of the H-Man will be developed which will be tested in a 12 subject Pilot study, refined and then used in a 44 subject Randomized Controlled Trial (RCT) study. At the same time, the feasibility of H-Man integration for a pared down home use model will be assessed in 4 subjects.
The investigators primary hypothesis is that sub-acute/chronic patients will exhibit clinically significant decreases of impairment when training with the H-Man combined with standard arm therapy on robot-measured scales and standardized clinical scales, at the level of elbow/shoulder after 18 sessions of training on the H-Man.
Condition or disease | Intervention/treatment | Phase |
---|---|---|
Stroke | Device: H-Man Other: Additional Conventional Therapy | Not Applicable |
Study Type : | Interventional (Clinical Trial) |
Actual Enrollment : | 44 participants |
Allocation: | Randomized |
Intervention Model: | Parallel Assignment |
Intervention Model Description: | H-Man training + conventional therapy vs equal amount of conventional therapy 1:1 allocation |
Masking: | Single (Outcomes Assessor) |
Masking Description: | Blinded therapist assessor to determine clinical outcomes at pre and post treatment and follow up. |
Primary Purpose: | Other |
Official Title: | Refinement and Clinical Evaluation of the H-Man: A Novel, Portable, Inexpensive Planar Robot for Arm Rehabilitation After Stroke |
Actual Study Start Date : | July 1, 2014 |
Actual Primary Completion Date : | December 31, 2017 |
Actual Study Completion Date : | March 31, 2018 |

Arm | Intervention/treatment |
---|---|
Experimental: H-Man
H-Man is a novel, portable, inexpensive end-effector upper limb robot.
|
Device: H-Man
H-man is a portable end-effector planar upper limb robot.
Other Name: No other names. |
Active Comparator: Additional Conventional Therapy
Repetitive goals based arm therapy
|
Other: Additional Conventional Therapy
Repetitive goals based arm therapy
Other Name: No other names |
- Change from Baseline in Fugl Meyer Assessment of Motor Recovery [ Time Frame: 0, 3, 6, 12 and 24 weeks after start of intervention ]As above
- Change from Baseline in Action Research Arm Test [ Time Frame: 0, 3, 6, 12 and 24 weeks after start of intervention ]As above

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study: | 21 Years to 85 Years (Adult, Older Adult) |
Sexes Eligible for Study: | All |
Accepts Healthy Volunteers: | No |
Inclusion Criteria:
- First ever clinical stroke (ischaemic or haemorrhagic) confirmed on brain imaging
- Duration post stroke: 3 months to 24 months
- Age 21 to 85 years
- Hemiplegic pattern of arm motor impairment with Shoulder abduction MRC motor power >/= 3/5 and elbow flexion MRC motor power >/= 3/5
- Affected upper limb Fugl Myer Motor Assessment (FMMA) scale 20-50
- And / or associated motor incoordination or motor ataxia
Exclusion Criteria:
- Non stroke related causes of arm motor impairment
- Medical conditions incompatible with research participation: uncontrolled medical illnesses (hypertension or diabetes, heart failure, asthma, depression, end stage renal failure, terminal malignancy), life expectancy <6 months, unhealed fractures or severe arm pain (visual analogue scale VAS > 5/10, pregnancy
- Inability to tolerate sitting for 90 minutes.
- Local factors which preclude robotic interfacing or may be worsened by intensive arm therapy: spasticity of Modified Ashworth Scale grades 3-4, skin wounds, shoulder pain VAS >5/10, active fractures or arthritis or fixed flexion contractures of shoulder, elbow, wrist or fingers incompatible with interface with the H-man robot.
- Severe sensory impairment of affected limb
- Severe visual impairment, hemispatial neglect or homonymous hemianopia
- Cognitive impairments or uncontrolled behaviour. (Folstein mini mental state exam MMSE <26/28)

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT02188628
Singapore | |
Tan Tock Seng Rehabilitation Centre | |
Singapore, Singapore, 569766 |
Principal Investigator: | Chua SG Sui Geok, MBBS,FRCP | Tan Tock Seng Hospital |
Responsible Party: | Chua Sui Geok, Karen, Senior Consultant, Tan Tock Seng Hospital |
ClinicalTrials.gov Identifier: | NCT02188628 |
Other Study ID Numbers: |
2014/00122 |
First Posted: | July 11, 2014 Key Record Dates |
Last Update Posted: | September 12, 2019 |
Last Verified: | September 2019 |
Individual Participant Data (IPD) Sharing Statement: | |
Plan to Share IPD: | No |
Motor recovery, robotics, stroke rehabilitation |
Stroke Cerebrovascular Disorders Brain Diseases Central Nervous System Diseases |
Nervous System Diseases Vascular Diseases Cardiovascular Diseases |